AAAAAA

   
Results: 1-24 |
Results: 24
MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS AFTER INDUCTION CHEMOTHERAPY RUBICIN-VINORELBINE-CYCLOPHOSPHAMIDE-FLUOROURACIL) AND GRANULOCYTE-COLONY-STIMULATING FACTOR IN BREAST-CANCER
Authors: CHARRIER S CHASSAGNE J CURE H BAY JO COMMUNAL Y PORTEFAIX G FERRIERE JP BETAIL G PLAGNE R CHOLLET P
Citation: S. Charrier et al., MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS AFTER INDUCTION CHEMOTHERAPY RUBICIN-VINORELBINE-CYCLOPHOSPHAMIDE-FLUOROURACIL) AND GRANULOCYTE-COLONY-STIMULATING FACTOR IN BREAST-CANCER, Bone marrow transplantation, 22(9), 1998, pp. 845-851
INTESTINAL PERFORATION COMPLICATING PRIMA RY CYTOMEGALOVIRUS-INFECTION IN A PATIENT RECEIVING TREATMENT FOR TESTICULAR CANCER
Authors: BEAL D BAY JO LEBOUEDEC G FERNANDEZ M CONDAT P DAUPLAT J PLAGNE R
Citation: D. Beal et al., INTESTINAL PERFORATION COMPLICATING PRIMA RY CYTOMEGALOVIRUS-INFECTION IN A PATIENT RECEIVING TREATMENT FOR TESTICULAR CANCER, La Semaine des hopitaux de Paris, 74(11-12), 1998, pp. 594-597
AUTOIMMUNE THROMBOCYTOPENIA AFTER 6 CYCLES OF FLUDARABINE PHOSPHATE IN A PATIENT WITH CHRONIC LYMPHOTIC LEUKEMIA
Authors: BAY JO FOUASSIER M BEAL D ALCARAZ L CURE H CHOLLET P PLAGNE R TRAVADE P
Citation: Jo. Bay et al., AUTOIMMUNE THROMBOCYTOPENIA AFTER 6 CYCLES OF FLUDARABINE PHOSPHATE IN A PATIENT WITH CHRONIC LYMPHOTIC LEUKEMIA, HEM CELL TH, 39(4), 1997, pp. 209-212
HIGH-DOSE CHEMOTHERAPY WITH HEMATOPOIETIC RESCUE IN PATIENTS WITH STAGE-III TO STAGE-IV OVARIAN-CANCER - LONG-TERM RESULTS
Authors: LEGROS M DAUPLAT J FLEURY J CURE H SUZANNE F CHASSAGNE J BAY JO SOL C CANIS M CONDAT P CHOUFI B TAVERNIER F GLENAT C CHOLLET P PLAGNE R
Citation: M. Legros et al., HIGH-DOSE CHEMOTHERAPY WITH HEMATOPOIETIC RESCUE IN PATIENTS WITH STAGE-III TO STAGE-IV OVARIAN-CANCER - LONG-TERM RESULTS, Journal of clinical oncology, 15(4), 1997, pp. 1302-1308
RHGM-CSF VS PLACEBO FOLLOWING RHGM-CSF-MOBILIZED PBPC TRANSPLANTATION- A PHASE-III DOUBLE-BLIND RANDOMIZED TRIAL
Authors: LEGROS M FLEURY J BAY JO CHOUFI B BASILE M CONDAT P GLENAT C COMMUNAL Y TAVERNIER F BONS JM CHOLLET P PLAGNE R CHASSAGNE J
Citation: M. Legros et al., RHGM-CSF VS PLACEBO FOLLOWING RHGM-CSF-MOBILIZED PBPC TRANSPLANTATION- A PHASE-III DOUBLE-BLIND RANDOMIZED TRIAL, Bone marrow transplantation, 19(3), 1997, pp. 209-213
HIGH-DOSE THERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN FIRSTCOMPLETE OR PARTIAL REMISSION FOR POOR-PROGNOSIS HODGKINS-DISEASE
Authors: FLEURY J LEGROS M COLOMBAT P CURE H TRAVADE P TORTOCHAUX J DIONET C CHOLLET P LINASSIER C LAMAGNERE JP BLAISE D VIENS P MARANINCHI D PLAGNE R
Citation: J. Fleury et al., HIGH-DOSE THERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN FIRSTCOMPLETE OR PARTIAL REMISSION FOR POOR-PROGNOSIS HODGKINS-DISEASE, Leukemia & lymphoma, 20(3-4), 1996, pp. 259-266
ADJUVANT TREATMENT OF NODE-POSITIVE BREAST-CANCER WITH CYCLOPHOSPHAMIDE, DOXORUBICIN, FLUOROURACIL AND VINCRISTINE VERSUS CYCLOPHOSPHAMIDE,METHOTREXATE, AND FLUOROURACIL - FINAL REPORT AFTER A 16-YEAR MEDIAN FOLLOW-UP DURATION
Authors: MISSET JL DIPALMA M DELGADO M PLAGNE R CHOLLET P FUMOLEAU P LEMEVEL B BELPOMME D GUERRIN J FARGEOT P METZ R ITHZAKI M HILL C MATHE G
Citation: Jl. Misset et al., ADJUVANT TREATMENT OF NODE-POSITIVE BREAST-CANCER WITH CYCLOPHOSPHAMIDE, DOXORUBICIN, FLUOROURACIL AND VINCRISTINE VERSUS CYCLOPHOSPHAMIDE,METHOTREXATE, AND FLUOROURACIL - FINAL REPORT AFTER A 16-YEAR MEDIAN FOLLOW-UP DURATION, Journal of clinical oncology, 14(4), 1996, pp. 1136-1145
INTEREST OF HIGH FLUORESCENCE RETICULOCYTES (HFR)EVALUATION IN OPTIMAL TIME DETERMINATION OF PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) HAVESTING
Authors: PORTEFAIX G COMMUNAL Y FLEURY J CURE H CHOUFI B FOUASSIER M BONS JM GLENAT C CHOLLET P CHASSAGNE J PLAGNE R LEGROS M
Citation: G. Portefaix et al., INTEREST OF HIGH FLUORESCENCE RETICULOCYTES (HFR)EVALUATION IN OPTIMAL TIME DETERMINATION OF PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) HAVESTING, Blood, 88(10), 1996, pp. 3721-3721
A CASE OF ISOLATED ADRENAL METASTASIS FRO M A CUTANEOUS MALIGNANT-MELANOMA TREATED BY EXCISION WITH A 3-YEAR SURVIVAL
Authors: CLAUDE R SALE JM CAVILLON C RIGONDET G DESPLECHAIN C EGLOFF H FRANCK F GOUJON N LAUTIER A PLAGNE R
Citation: R. Claude et al., A CASE OF ISOLATED ADRENAL METASTASIS FRO M A CUTANEOUS MALIGNANT-MELANOMA TREATED BY EXCISION WITH A 3-YEAR SURVIVAL, Annales d'Urologie, 30(1), 1996, pp. 44-45
IS NAVOBAN(R) (TROPISETRON) AS EFFECTIVE AS ZOFRAN(R) (ONDANSETRON) IN CISPLATIN-INDUCED EMESIS
Authors: MARTY M KLEISBAUER JP FOURNEL P VERGNENEGRE A CARLES P LORIAKANZA Y SIMONETTA C DEBRUIJN KM LAURAINE P DIDIER A CUPISSOL D BERGERAT JP PUJAZON MC HERON JF DRENO B TAYTARD A GUERIN JC CLAVIER J ROBINET G BLANCHON F BALMES P MUIR JF PAILLOTIN D POIRIER R BONNETERRE J MELLONI B ROCHE H DEPIERRE A PLAGNE R SOUQUET PJ ARMAND JP DEFORNI M
Citation: M. Marty et al., IS NAVOBAN(R) (TROPISETRON) AS EFFECTIVE AS ZOFRAN(R) (ONDANSETRON) IN CISPLATIN-INDUCED EMESIS, Anti-cancer drugs, 6, 1995, pp. 15-21
NEW METHOD FAIR STEM-CELL QUANTIFICATION - APPLICATIONS TO THE MANAGEMENT OF PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION
Authors: LEGROS M FLEURY J CURE H CONDAT P LENAT A SUBTIL E SANDERSON D COMMUNAL Y BASILE M TAVERNIER F CHOUFFI B CHOLLET P PLAGNE R CHASSAGNE J
Citation: M. Legros et al., NEW METHOD FAIR STEM-CELL QUANTIFICATION - APPLICATIONS TO THE MANAGEMENT OF PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION, Bone marrow transplantation, 15(1), 1995, pp. 1-8
ARTERIAL THROMBOSIS DURING CHEMOTHERAPY F OR AN EXTRAGONADAL DYSGERMINOMA
Authors: SCHMIDT J ZENUT M DEMARQUILLY F MACIEJEWSKI C PLAGNE R LAVARENNE J
Citation: J. Schmidt et al., ARTERIAL THROMBOSIS DURING CHEMOTHERAPY F OR AN EXTRAGONADAL DYSGERMINOMA, Therapie, 50(5), 1995, pp. 476-478
TUMOR-REGRESSION RESPONSES IN MELANOMA PATIENTS TREATED WITH A PEPTIDE ENCODED BY GENE MAGE-3
Authors: MARCHAND M WEYNANTS P RANKIN E ARIENTI F BELLI F PARMIANI G CASCINELLI N BOURLOND A VANWIJCK R HUMBLET Y CANON JL LAURENT C NAEYAERT JM PLAGNE R DERAEMAEKER R KNUTH A JAGER E BRASSEUR F HERMAN J COULIE PG BOON T
Citation: M. Marchand et al., TUMOR-REGRESSION RESPONSES IN MELANOMA PATIENTS TREATED WITH A PEPTIDE ENCODED BY GENE MAGE-3, International journal of cancer, 63(6), 1995, pp. 883-885
THE HEMATOPOIETIC STEM-CELL TRANSPLANTATION IN HODGKINS-DISEASE - QUESTIONS AND CONTROVERSIES
Authors: FLEURY J LEGROS M CURE H TORTOCHAUX J CONDAT P DIONET C TRAVADE P BELEMBAOGO E TAVERNIER F KWIATKOWSKI F CHOLLET P PLAGNE R
Citation: J. Fleury et al., THE HEMATOPOIETIC STEM-CELL TRANSPLANTATION IN HODGKINS-DISEASE - QUESTIONS AND CONTROVERSIES, Leukemia & lymphoma, 15(5-6), 1994, pp. 419-432
ASSOCIATION OF BREAST-CANCER AND KLINEFEL TERS-SYNDROME
Authors: BEAL D FLEURY J CURE H SUREAU I LEBOUEDEC G DELATOUR M PLAGNE R
Citation: D. Beal et al., ASSOCIATION OF BREAST-CANCER AND KLINEFEL TERS-SYNDROME, La Semaine des hopitaux de Paris, 70(9-10), 1994, pp. 282-283
LOW-GRADE SUPRATENTORIAL ASTROCYTOMAS - MANAGEMENT AND PROGNOSTIC FACTORS
Authors: JANNY P CURE H MOHR M HELDT N KWIATKOWSKI F LEMAIRE JJ PLAGNE R ROZAN R
Citation: P. Janny et al., LOW-GRADE SUPRATENTORIAL ASTROCYTOMAS - MANAGEMENT AND PROGNOSTIC FACTORS, Cancer, 73(7), 1994, pp. 1937-1945
PRONOSTIC VALUE OF BETA-2-MICROGLOBULIN I N YOUNG-ADULTS WITH HODGKINS-DISEASE
Authors: FLEURY J TORTOCHAUX J LEGROS M CURE H KWIATKOWSKI F FERRIERE JP TRAVADE P DIONET C GAILLARD G CHASSAGNE J BIGNON YJ VANPRAAGH I BELEMBAOGO E CHOLLET P PLAGNE R
Citation: J. Fleury et al., PRONOSTIC VALUE OF BETA-2-MICROGLOBULIN I N YOUNG-ADULTS WITH HODGKINS-DISEASE, Bulletin du cancer, 81(7), 1994, pp. 625-631
R-HU GM-CSF AFTER HIGH-DOSE CHEMOTHERAPY (HDC) AND PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) RESCUE - AN UNICENTER RANDOMIZED STUDY OF 50 PATIENTS
Authors: LEGROS M FLEURY J CURE H BASILE M CHOUFI B COMMUNAL Y CHOLLET P TRAVADE P CONDAT P PLAGNE R CHASSAGNE J
Citation: M. Legros et al., R-HU GM-CSF AFTER HIGH-DOSE CHEMOTHERAPY (HDC) AND PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) RESCUE - AN UNICENTER RANDOMIZED STUDY OF 50 PATIENTS, Blood, 84(10), 1994, pp. 10000090-10000090
IS ESOPHAGEAL CANCER CHEMOSENSITIVE - SIG NIFICANCE OF A COMBINATION OF 2 PLATINUM SALTS (CARBOPLATIN AND CISPLATIN) AND FLUOROURACIL
Authors: CURE H PEZET D FLEURY J SLIM K CHOLLET P PLAGNE R CHIPPONI J
Citation: H. Cure et al., IS ESOPHAGEAL CANCER CHEMOSENSITIVE - SIG NIFICANCE OF A COMBINATION OF 2 PLATINUM SALTS (CARBOPLATIN AND CISPLATIN) AND FLUOROURACIL, La Revue de medecine interne, 14(6), 1993, pp. 413-413
THE ANTIEMETIC EFFICACY AND SAFETY OF GRANISETRON COMPARED WITH METOCLOPRAMIDE PLUS DEXAMETHASONE IN PATIENTS RECEIVING FRACTIONATED CHEMOTHERAPY OVER 5 DAYS
Authors: AAPRO M PIGUET D GIGER K BAUER J HAEFLIGER JM BREMER K CALS L CATTAN A CLAVEL M CZYGAN P DEARNALEY D DIEHL V HARJUNG M HARPER P ILLIGER H KAYE S KEIZER HJ KERBRAT P KONIG HJ MONCUQUET P DEBESANCON C NAMER M NOBEL A NORTIER JWR OBERLING F PLAGNE R REICHLE A RIVIERE A SOUKOP M VEENHOF CHN ZYLBERAIT D HUNTER B
Citation: M. Aapro et al., THE ANTIEMETIC EFFICACY AND SAFETY OF GRANISETRON COMPARED WITH METOCLOPRAMIDE PLUS DEXAMETHASONE IN PATIENTS RECEIVING FRACTIONATED CHEMOTHERAPY OVER 5 DAYS, Journal of cancer research and clinical oncology, 119(9), 1993, pp. 555-559
LINEAGE PROMISCUITY IN LEUKEMIA STUDIES OF T-CELL RECEPTOR AND IMMUNOGLOBULIN GENES
Authors: BERNARD D BIGNON YJ LAVENUE F PAUCHARD J DEMEOCQ F TRAVADE P PHILIPPE P LEGROS M CURE H CHASSAGNE J CHOLLET P PLAGNE R
Citation: D. Bernard et al., LINEAGE PROMISCUITY IN LEUKEMIA STUDIES OF T-CELL RECEPTOR AND IMMUNOGLOBULIN GENES, Leukemia research, 17(5), 1993, pp. 445-453
GENETIC PREDISPOSITION TO BREAST-CANCER A ND OVARIAN-CANCER
Authors: LALLE P STOPPALYONNET D MAZOYER S RIO P GIRODET C HARDOUIN A NAROD SA SOBOL H BIGNON YJ LARRA F LORTHOLARY A PIET L LAITHIER V VUILLIER J DILHUYDY MH LONGY M TOULOUSE C COUETTE JE HARDOUIN A SWITSUS O CHAMOUTON C BIGNON YJ PLAGNE R PETIT MF CURE H CUISENIER J LIZARD S",NIVELON,"TEYSSIER JY",MOUSSEAU,"LEROUX D",VROUSOS,SCHAERER,"VENNIN P DEMAILLE MC DECIGNY N GRANIER AM DEYRAT JP SOBOL H DESSEIGNE F FRAPPAZ D FERVERS B EISINGER F",FABBRO,"LUPORSI E LEHEUP B SOMMELET D MAUGAUDLOUBOUTIN C FRENAY M GESTA P THOMAS G OLSCHWANG S DELETTRE O AURIAS A",ZUMMER,"HAGUENAUER O GRANDJOUAN S DEMANGE L DANELMOORE L LEVEQUE J NOGUES C PETIT JC FRICKER JP LIMACHER JM ROUMAGNAC M LAPEYRE M DREYFUS HR GRANDJOUAN S SCHLUMBERGER M BRUGIERES L JANIN N AVRIL MF
Citation: P. Lalle et al., GENETIC PREDISPOSITION TO BREAST-CANCER A ND OVARIAN-CANCER, Bulletin du cancer, 80(10), 1993, pp. 857-865
A NEW METHOD OF STEM-CELL QUANTIFICATION - PRACTICAL APPLICATIONS IN THE MANAGEMENT OF PBPC TRANSPLANTATION
Authors: LEGROS M FLEURY J CURE H BASILE M SOL C CONDAT P KWIATKOWSKI F PLAGNE R CHASSAGNE J
Citation: M. Legros et al., A NEW METHOD OF STEM-CELL QUANTIFICATION - PRACTICAL APPLICATIONS IN THE MANAGEMENT OF PBPC TRANSPLANTATION, Blood, 82(10), 1993, pp. 10000082-10000082
PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) MOBILIZATION AFTER HIGH-DOSE OF CYCLOPHOSPHAMIDE (CTX) PLUS ETOPOSIDE (VP16) AND RHU-GM-CSF (MOLGRAMOSTIM)
Authors: LEGROS M FLEURY J BASILE M CURE H TAVERNIER F CONDAT P CHOLLET P PLAGNE R CHASSAGNE J
Citation: M. Legros et al., PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) MOBILIZATION AFTER HIGH-DOSE OF CYCLOPHOSPHAMIDE (CTX) PLUS ETOPOSIDE (VP16) AND RHU-GM-CSF (MOLGRAMOSTIM), Blood, 82(10), 1993, pp. 10000635-10000635
Risultati: 1-24 |